Pluripotent stem cells are embryonic stem cells that have the potential to form all adult cell types and help in repairing of damaged tissues in the human body. An induced pluripotent stem cells, or iPSCs, are taken from any tissue (usually skin or blood) from a child or an adult and is genetically modified to behave like pluripotent stem cells or embryonic stem cells.
iPSCs market is in emerging state mainly due to its ability to make any cell or tissue the body might need to encounter wide range of diseases like diabetes, spinal cord injury, leukaemia or heart disease, these cells can potentially be customized to provide a perfect genetic match for any patient.
Market Analysis and Insights: Global Induced Pluripotent Stem Cells Market
The research report studies the Induced Pluripotent Stem Cells market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Induced Pluripotent Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Induced Pluripotent Stem Cells Scope and Segment
The global Induced Pluripotent Stem Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Induced Pluripotent Stem Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
by Application, this report covers the following segments
Academic Research
Drug Development And Discovery
Toxicity Screening
Regenerative Medicine
Others
Global Induced Pluripotent Stem Cells market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Induced Pluripotent Stem Cells key players in this market include:
Fujifilm Holding Corporation
Astellas Pharma
Fate Therapeutics
Bristol-Myers Squibb Company
ViaCyte
Celgene Corporation
Aastrom Biosciences
Acelity Holdings
StemCells
Japan Tissue Engineering
Organogenesis
iPSCs market is in emerging state mainly due to its ability to make any cell or tissue the body might need to encounter wide range of diseases like diabetes, spinal cord injury, leukaemia or heart disease, these cells can potentially be customized to provide a perfect genetic match for any patient.
Market Analysis and Insights: Global Induced Pluripotent Stem Cells Market
The research report studies the Induced Pluripotent Stem Cells market using different methodologies and analyzes to provide accurate and in-depth information about the market. For a clearer understanding, it is divided into several parts to cover different aspects of the market. Each area is then elaborated to help the reader comprehend the growth potential of each region and its contribution to the global market. The researchers have used primary and secondary methodologies to collate the information in the report. They have also used the same data to generate the current market scenario. This report is aimed at guiding people towards an apprehensive, better, and clearer knowledge of the market.
The global Induced Pluripotent Stem Cells market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Induced Pluripotent Stem Cells Scope and Segment
The global Induced Pluripotent Stem Cells market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Induced Pluripotent Stem Cells market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026.
by Type, the market is primarily split into
Hepatocytes
Fibroblasts
Keratinocytes
Amniotic Cells
Others
by Application, this report covers the following segments
Academic Research
Drug Development And Discovery
Toxicity Screening
Regenerative Medicine
Others
Global Induced Pluripotent Stem Cells market: regional analysis, the major regions covered in the report are:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
The report lists the major players in the regions and their respective market share on the basis of global revenue. It also explains their strategic moves in the past few years, investments in product innovation, and changes in leadership to stay ahead in the competition. This will give the reader an edge over others as a well-informed decision can be made looking at the holistic picture of the market.
The Induced Pluripotent Stem Cells key players in this market include:
Fujifilm Holding Corporation
Astellas Pharma
Fate Therapeutics
Bristol-Myers Squibb Company
ViaCyte
Celgene Corporation
Aastrom Biosciences
Acelity Holdings
StemCells
Japan Tissue Engineering
Organogenesis
1 Market Overview of Induced Pluripotent Stem Cells
1.1 Induced Pluripotent Stem Cells Market Overview
1.1.1 Induced Pluripotent Stem Cells Product Scope
1.1.2 Market Status and Outlook
1.2 Global Induced Pluripotent Stem Cells Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Induced Pluripotent Stem Cells Market Size by Region (2015-2026)
1.4 Global Induced Pluripotent Stem Cells Historic Market Size by Region (2015-2020)
1.5 Global Induced Pluripotent Stem Cells Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.1 North America Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.2 Europe Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.4 Latin America Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
2 Induced Pluripotent Stem Cells Market Overview by Type
2.1 Global Induced Pluripotent Stem Cells Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Induced Pluripotent Stem Cells Historic Market Size by Type (2015-2020)
2.3 Global Induced Pluripotent Stem Cells Forecasted Market Size by Type (2021-2026)
2.4 Hepatocytes
2.5 Fibroblasts
2.6 Keratinocytes
2.7 Amniotic Cells
2.8 Others
3 Induced Pluripotent Stem Cells Market Overview by Application
3.1 Global Induced Pluripotent Stem Cells Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Induced Pluripotent Stem Cells Historic Market Size by Application (2015-2020)
3.3 Global Induced Pluripotent Stem Cells Forecasted Market Size by Application (2021-2026)
3.4 Academic Research
3.5 Drug Development And Discovery
3.6 Toxicity Screening
3.7 Regenerative Medicine
3.8 Others
4 Global Induced Pluripotent Stem Cells Competition Analysis by Players
4.1 Global Induced Pluripotent Stem Cells Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells as of 2019)
4.3 Date of Key Manufacturers Enter into Induced Pluripotent Stem Cells Market
4.4 Global Top Players Induced Pluripotent Stem Cells Headquarters and Area Served
4.5 Key Players Induced Pluripotent Stem Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Induced Pluripotent Stem Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Fujifilm Holding Corporation
5.1.1 Fujifilm Holding Corporation Profile
5.1.2 Fujifilm Holding Corporation Main Business
5.1.3 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Products, Services and Solutions
5.1.4 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.1.5 Fujifilm Holding Corporation Recent Developments
5.2 Astellas Pharma
5.2.1 Astellas Pharma Profile
5.2.2 Astellas Pharma Main Business
5.2.3 Astellas Pharma Induced Pluripotent Stem Cells Products, Services and Solutions
5.2.4 Astellas Pharma Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.2.5 Astellas Pharma Recent Developments
5.3 Fate Therapeutics
5.5.1 Fate Therapeutics Profile
5.3.2 Fate Therapeutics Main Business
5.3.3 Fate Therapeutics Induced Pluripotent Stem Cells Products, Services and Solutions
5.3.4 Fate Therapeutics Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.3.5 Bristol-Myers Squibb Company Recent Developments
5.4 Bristol-Myers Squibb Company
5.4.1 Bristol-Myers Squibb Company Profile
5.4.2 Bristol-Myers Squibb Company Main Business
5.4.3 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.4.5 Bristol-Myers Squibb Company Recent Developments
5.5 ViaCyte
5.5.1 ViaCyte Profile
5.5.2 ViaCyte Main Business
5.5.3 ViaCyte Induced Pluripotent Stem Cells Products, Services and Solutions
5.5.4 ViaCyte Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.5.5 ViaCyte Recent Developments
5.6 Celgene Corporation
5.6.1 Celgene Corporation Profile
5.6.2 Celgene Corporation Main Business
5.6.3 Celgene Corporation Induced Pluripotent Stem Cells Products, Services and Solutions
5.6.4 Celgene Corporation Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.6.5 Celgene Corporation Recent Developments
5.7 Aastrom Biosciences
5.7.1 Aastrom Biosciences Profile
5.7.2 Aastrom Biosciences Main Business
5.7.3 Aastrom Biosciences Induced Pluripotent Stem Cells Products, Services and Solutions
5.7.4 Aastrom Biosciences Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.7.5 Aastrom Biosciences Recent Developments
5.8 Acelity Holdings
5.8.1 Acelity Holdings Profile
5.8.2 Acelity Holdings Main Business
5.8.3 Acelity Holdings Induced Pluripotent Stem Cells Products, Services and Solutions
5.8.4 Acelity Holdings Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.8.5 Acelity Holdings Recent Developments
5.9 StemCells
5.9.1 StemCells Profile
5.9.2 StemCells Main Business
5.9.3 StemCells Induced Pluripotent Stem Cells Products, Services and Solutions
5.9.4 StemCells Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.9.5 StemCells Recent Developments
5.10 Japan Tissue Engineering
5.10.1 Japan Tissue Engineering Profile
5.10.2 Japan Tissue Engineering Main Business
5.10.3 Japan Tissue Engineering Induced Pluripotent Stem Cells Products, Services and Solutions
5.10.4 Japan Tissue Engineering Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.10.5 Japan Tissue Engineering Recent Developments
5.11 Organogenesis
5.11.1 Organogenesis Profile
5.11.2 Organogenesis Main Business
5.11.3 Organogenesis Induced Pluripotent Stem Cells Products, Services and Solutions
5.11.4 Organogenesis Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.11.5 Organogenesis Recent Developments
6 North America
6.1 North America Induced Pluripotent Stem Cells Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Induced Pluripotent Stem Cells Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Induced Pluripotent Stem Cells Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Induced Pluripotent Stem Cells Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Induced Pluripotent Stem Cells Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
1.1 Induced Pluripotent Stem Cells Market Overview
1.1.1 Induced Pluripotent Stem Cells Product Scope
1.1.2 Market Status and Outlook
1.2 Global Induced Pluripotent Stem Cells Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Induced Pluripotent Stem Cells Market Size by Region (2015-2026)
1.4 Global Induced Pluripotent Stem Cells Historic Market Size by Region (2015-2020)
1.5 Global Induced Pluripotent Stem Cells Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.1 North America Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.2 Europe Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.3 Asia-Pacific Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.4 Latin America Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
1.6.5 Middle East & Africa Induced Pluripotent Stem Cells Market Size YoY Growth (2015-2026)
2 Induced Pluripotent Stem Cells Market Overview by Type
2.1 Global Induced Pluripotent Stem Cells Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Induced Pluripotent Stem Cells Historic Market Size by Type (2015-2020)
2.3 Global Induced Pluripotent Stem Cells Forecasted Market Size by Type (2021-2026)
2.4 Hepatocytes
2.5 Fibroblasts
2.6 Keratinocytes
2.7 Amniotic Cells
2.8 Others
3 Induced Pluripotent Stem Cells Market Overview by Application
3.1 Global Induced Pluripotent Stem Cells Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Induced Pluripotent Stem Cells Historic Market Size by Application (2015-2020)
3.3 Global Induced Pluripotent Stem Cells Forecasted Market Size by Application (2021-2026)
3.4 Academic Research
3.5 Drug Development And Discovery
3.6 Toxicity Screening
3.7 Regenerative Medicine
3.8 Others
4 Global Induced Pluripotent Stem Cells Competition Analysis by Players
4.1 Global Induced Pluripotent Stem Cells Market Size by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Induced Pluripotent Stem Cells as of 2019)
4.3 Date of Key Manufacturers Enter into Induced Pluripotent Stem Cells Market
4.4 Global Top Players Induced Pluripotent Stem Cells Headquarters and Area Served
4.5 Key Players Induced Pluripotent Stem Cells Product Solution and Service
4.6 Competitive Status
4.6.1 Induced Pluripotent Stem Cells Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Fujifilm Holding Corporation
5.1.1 Fujifilm Holding Corporation Profile
5.1.2 Fujifilm Holding Corporation Main Business
5.1.3 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Products, Services and Solutions
5.1.4 Fujifilm Holding Corporation Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.1.5 Fujifilm Holding Corporation Recent Developments
5.2 Astellas Pharma
5.2.1 Astellas Pharma Profile
5.2.2 Astellas Pharma Main Business
5.2.3 Astellas Pharma Induced Pluripotent Stem Cells Products, Services and Solutions
5.2.4 Astellas Pharma Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.2.5 Astellas Pharma Recent Developments
5.3 Fate Therapeutics
5.5.1 Fate Therapeutics Profile
5.3.2 Fate Therapeutics Main Business
5.3.3 Fate Therapeutics Induced Pluripotent Stem Cells Products, Services and Solutions
5.3.4 Fate Therapeutics Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.3.5 Bristol-Myers Squibb Company Recent Developments
5.4 Bristol-Myers Squibb Company
5.4.1 Bristol-Myers Squibb Company Profile
5.4.2 Bristol-Myers Squibb Company Main Business
5.4.3 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Products, Services and Solutions
5.4.4 Bristol-Myers Squibb Company Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.4.5 Bristol-Myers Squibb Company Recent Developments
5.5 ViaCyte
5.5.1 ViaCyte Profile
5.5.2 ViaCyte Main Business
5.5.3 ViaCyte Induced Pluripotent Stem Cells Products, Services and Solutions
5.5.4 ViaCyte Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.5.5 ViaCyte Recent Developments
5.6 Celgene Corporation
5.6.1 Celgene Corporation Profile
5.6.2 Celgene Corporation Main Business
5.6.3 Celgene Corporation Induced Pluripotent Stem Cells Products, Services and Solutions
5.6.4 Celgene Corporation Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.6.5 Celgene Corporation Recent Developments
5.7 Aastrom Biosciences
5.7.1 Aastrom Biosciences Profile
5.7.2 Aastrom Biosciences Main Business
5.7.3 Aastrom Biosciences Induced Pluripotent Stem Cells Products, Services and Solutions
5.7.4 Aastrom Biosciences Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.7.5 Aastrom Biosciences Recent Developments
5.8 Acelity Holdings
5.8.1 Acelity Holdings Profile
5.8.2 Acelity Holdings Main Business
5.8.3 Acelity Holdings Induced Pluripotent Stem Cells Products, Services and Solutions
5.8.4 Acelity Holdings Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.8.5 Acelity Holdings Recent Developments
5.9 StemCells
5.9.1 StemCells Profile
5.9.2 StemCells Main Business
5.9.3 StemCells Induced Pluripotent Stem Cells Products, Services and Solutions
5.9.4 StemCells Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.9.5 StemCells Recent Developments
5.10 Japan Tissue Engineering
5.10.1 Japan Tissue Engineering Profile
5.10.2 Japan Tissue Engineering Main Business
5.10.3 Japan Tissue Engineering Induced Pluripotent Stem Cells Products, Services and Solutions
5.10.4 Japan Tissue Engineering Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.10.5 Japan Tissue Engineering Recent Developments
5.11 Organogenesis
5.11.1 Organogenesis Profile
5.11.2 Organogenesis Main Business
5.11.3 Organogenesis Induced Pluripotent Stem Cells Products, Services and Solutions
5.11.4 Organogenesis Induced Pluripotent Stem Cells Revenue (US$ Million) & (2015-2020)
5.11.5 Organogenesis Recent Developments
6 North America
6.1 North America Induced Pluripotent Stem Cells Market Size by Country
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Induced Pluripotent Stem Cells Market Size by Country
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Induced Pluripotent Stem Cells Market Size by Region
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Induced Pluripotent Stem Cells Market Size by Country
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Induced Pluripotent Stem Cells Market Size by Country
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Induced Pluripotent Stem Cells Market Dynamics
11.1 Industry Trends
11.2 Market Drivers
11.3 Market Challenges
11.4 Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
